» Authors » Frank J P Hoebers

Frank J P Hoebers

Explore the profile of Frank J P Hoebers including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 57
Citations 807
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Moreno A, Watson E, Humbert-Vidan L, Peterson D, van Dijk L, Urbano T, et al.
Int J Radiat Oncol Biol Phys . 2025 Jan; PMID: 39826846
Purpose: Osteoradionecrosis of the jaw (ORNJ) is a severe iatrogenic disease characterized by bone death after radiation therapy (RT) to the head and neck. With over 9 published definitions and...
2.
van Rijn-Dekker M, van der Schaaf A, Nienhuis S, Arents-Huls A, Ger R, Hamming-Vrieze O, et al.
Cancers (Basel) . 2025 Jan; 16(24. PMID: 39766181
Background/objectives: Studies have shown that dose to the parotid gland stem cell rich (SCR) regions should be reduced to lower the risk of xerostomia after radiotherapy (RT). This study aimed...
3.
Hoebers F, Wee L, Likitlersuang J, Mak R, Bitterman D, Huang Y, et al.
BJR Open . 2024 Nov; 6(1):tzae039. PMID: 39583148
The use of artificial intelligence (AI) holds great promise for radiation oncology, with many applications being reported in the literature, including some of which are already in clinical use. These...
4.
de Leeuw A, Giralt J, Tao Y, Benavente S, Nguyen T, Hoebers F, et al.
Radiother Oncol . 2024 Nov; 202:110612. PMID: 39522824
Purpose: To report on quality assurance (QA) and protocol adherence (PA) in a multicentre phase III trial for head and neck cancer, evaluate patterns of protocol deviations and investigate the...
5.
de Leeuw A, Giralt J, Tao Y, Benavente S, France Nguyen T, Hoebers F, et al.
Radiother Oncol . 2024 Apr; 196:110281. PMID: 38636708
Background And Purpose: This multicenter randomized phase III trial evaluated whether locoregional control of patients with LAHNSCC could be improved by fluorodeoxyglucose-positron emission tomography (FDG-PET)-guided dose-escalation while minimizing the risk...
6.
Buurman D, Speksnijder C, Granzier M, Timmer V, Hoebers F, Kessler P
Radiother Oncol . 2023 Nov; 190:110026. PMID: 38008415
No abstract available.
7.
Buurman D, Speksnijder C, Granzier M, Timmer V, Hoebers F, Kessler P
Radiother Oncol . 2023 Aug; 187:109847. PMID: 37543058
Background And Purpose: Prior to radiotherapy (RT), teeth with poor prognosis that pose a risk for post-RT osteoradionecrosis (ORN) are removed. To allow enough time for adequate wound healing prior...
8.
Luyendijk M, Visser O, Blommestein H, de Hingh I, Hoebers F, Jager A, et al.
J Natl Cancer Inst . 2023 Mar; 115(6):628-635. PMID: 36978244
Background: Over the past decades, the therapeutic landscape has markedly changed for patients with metastatic solid cancer, yet few studies have evaluated its effect on population-based survival. The objective of...
9.
Willemsen A, Pilz W, Hoeben A, Hoebers F, Schols A, Baijens L
Head Neck . 2022 Dec; 45(4):783-797. PMID: 36583567
Background: This study aims to investigate the relationship between cancer cachexia and oropharyngeal dysphagia (OD) in patients with head and neck cancer (HNC) prior to chemoradiotherapy or bioradiotherapy (CRT/BRT). Methods:...
10.
Leeuwenberg A, Reitsma J, Van den Bosch L, Hoogland J, van der Schaaf A, Hoebers F, et al.
Radiother Oncol . 2022 Dec; 179:109449. PMID: 36566991
Background: Normal-tissue complication probability (NTCP) models predict complication risk in patients receiving radiotherapy, considering radiation dose to healthy tissues, and are used to select patients for proton therapy, based on...